Upgrade to SI Premium - Free Trial

Quest Diagnostics (DGX) PT Lowered to $103 at Mizuho Securities

October 19, 2017 5:19 PM
Mizuho Securities lowered its price target on Quest Diagnostics (NYSE: DGX) to $103.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles